The Healthcare Investor

Latest from The Healthcare Investor - Page 42

McGuireWoods has long been an avid supporter of the advancement of professional women. As part of our initiative seeking to expand the leadership of women in private equity, we are continuing our series of profiling women leaders in private equity. We are hopeful that this series will serve to inspire other women to pursue their

Viewside Capital Partners and Morningside Group have co-led a $15 million series A funding round in Resilience Lab, according to a news release.

Resilience Lab, based in New York, is a mental health technology company. Founded in 2019, the company’s platform is designed to help clients connect to therapists and participate in in-person,

Accelmed Partners has announced it has invested $35 million in SKNV.

SKNV, based in Pompano Beach, Fla., develops medications and skincare solutions for dermatology practices. Founded in 2016 and formerly Sincerus Pharmaceuticals and Prescriber’s Choice, SKNV states it produces medicines for the 12 most common dermatological diagnoses.

Accelmed, based in Aventura, Fla., is a

The Vistria Group and GHO Capital Partners will acquire a controlling interest in Alcami Corp. from Madison Dearborn Partners (MDP) and Ampersand Capital Partners, according to a news release.

Alcami, based in Wilmington, N.C., is a contract development, testing and manufacturing organization for pharma and biotech companies. Founded in 1979, the company provides

GTCR has announced it has acquired Biocoat Holdings.

Biocoat, based in Horsham, Pa., is a provider of medical coatings products and services for medical devices in the interventional sector. Founded in 1991, the company specializes in biocompatible hydrophilic coatings.

GTCR, based in Chicago, pursues a wide range of investments in several industries, including healthcare.

Avista Capital Partners has announced its acquisition of Taconic Biosciences from H.I.G. Capital. 

Taconic, based in Rensselaer, N.Y., is a provider of genetically engineered research models and related services. Founded in 1952, the company specializes in murine models for use in drug discovery research and non-clinical safety testing.

Avista, based in New York,

RC Capital (RCC) has announced it has closed a growth and recapitalization investment in Cognitive Research Corporation (CRC).

CRC, based in St. Petersburg, Fla., is contract research organization that specializes in central nervous system product development. Founded in 2006, the company sells to pharmaceutical, nutraceutical, biotechnology and medical device companies.

RCC, based in Cincinnati, Ohio,